GP1BA: A Potential Drug Target and Biomarker for Platelet Function
GP1BA: A Potential Drug Target and Biomarker for Platelet Function
Platelets are essential components of the blood system, as they play a crucial role in blood clotting and wound healing. Their functions are regulated by a complex network of proteins, including platelet glycoprotein (GP) Ib alpha polypeptide (GP1BA). GP1BA is a 140 -kDa protein that is expressed in high levels in platelets and is involved in several important functions, including hemostasis, thrombosis, and platelet-derived growth factor (PDGF) signaling.
GP1BA functions as a receptor for several different proteins, including Fc portion of the integrin 伪IIb尾3 complex, PDGF, and thrombin. These interactions between GP1BA and these proteins contribute to its role in platelet function and thrombosis.
One of the key functions of GP1BA is its role in hemostasis, the process by which the body forms a blood clot to stop bleeding. During hemostasis, GP1BA interacts with the Fc portion of the integrin 伪IIb尾3 complex to form a stable complex that is resistant to inhibition by factors such as thrombin. This interaction between GP1BA and the 伪IIb尾3 complex is critical for the formation of functional platelets during blood clots.
In addition to its role in hemostasis, GP1BA is also involved in thrombosis, the process by which a blood clot forms in the body. GP1BA has been shown to contribute to the formation of blood clots by interacting with PDGF and thrombin. These interactions can lead to the recruitment of additional platelets to the site of thrombosis, which can further contribute to the formation of the blood clot.
GP1BA has also been shown to play a role in the regulation of platelet-derived growth factor (PDGF) signaling. PDGF is a signaling protein that is involved in the growth and maintenance of platelets, among other functions. GP1BA has been shown to interact with PDGF and contribute to the regulation of PDGF signaling in platelets.
In addition to its role in hemostasis and thrombosis, GP1BA is also involved in other functions that are important for platelet function. For example, GP1BA has been shown to play a role in the regulation of platelet aggregation, the formation of platelet aggregates that can cause blood clots. Additionally, GP1BA has been shown to contribute to the regulation of platelet function during wound healing, the process by which the body forms new tissue after an injury.
Given the importance of GP1BA in platelet function, it is a potential drug target for researchers to study and develop new treatments for various platelet-related conditions. For example, researchers have been shown to be interested in developing new treatments for blood clots, which are a common condition that can be caused by a variety of factors, including cardiovascular disease, deep vein thrombosis, and trauma.
In addition to its potential as a drug target, GP1BA is also a potential biomarker for platelet function. The levels of GP1BA are often elevated in patients with certain platelet-related conditions, such as blood clots or wound healing disorders. This suggests that GP1BA may be a useful diagnostic or predictive marker for these conditions.
In conclusion, GP1BA is a protein that is involved in several important functions in the platelet system, including hemostasis, thrombosis, and PDGF signaling. It is a potential drug target and biomarker for various platelet-related conditions, and further research is needed to fully understand its role in platelet function.
Protein Name: Glycoprotein Ib Platelet Subunit Alpha
Functions: GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium
The "GP1BA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GP1BA comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GP1BB | GP2 | GP5 | GP6 | GP9 | GPA33 | GPAA1 | GPALPP1 | GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22
